Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones

The utilization of cardiac progenitor cells (CPCs) has been shown to induce favorable regenerative effects. While there are various populations of endogenous CPCs in the heart, there is no consensus regarding which population is ideal for cell-based regenerative therapy. Early-stage progenitor cells...

Full description

Bibliographic Details
Main Authors: Andrea Monteon, Lorelei Hughes, Victor Camberos, Mary Kearns-Jonker
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/2/1780
_version_ 1797441045465661440
author Andrea Monteon
Lorelei Hughes
Victor Camberos
Mary Kearns-Jonker
author_facet Andrea Monteon
Lorelei Hughes
Victor Camberos
Mary Kearns-Jonker
author_sort Andrea Monteon
collection DOAJ
description The utilization of cardiac progenitor cells (CPCs) has been shown to induce favorable regenerative effects. While there are various populations of endogenous CPCs in the heart, there is no consensus regarding which population is ideal for cell-based regenerative therapy. Early-stage progenitor cells can be differentiated into all cardiovascular lineages, including cardiomyocytes and endothelial cells. Identifying an Islet-1+ (Isl-1+) early-stage progenitor population with enhanced stemness, multipotency and differentiation potential would be beneficial for the development of novel regenerative therapies. Here, we investigated the transcriptome of human neonatal Isl-1+ CPCs. Isl-1+ human neonatal CPCs exhibit enhanced stemness properties and were found to express Spalt-like transcription factor 4 (SALL4). SALL4 plays a role in embryonic development as well as proliferation and expansion of hematopoietic progenitor cells. SALL4, SOX2, EpCAM and TBX5 are co-expressed in the majority of Isl-1+ clones isolated from neonatal patients. The pre-mesendodermal transcript TFAP2C was identified in select Isl-1, SALL4, SOX2, EpCAM and TBX5 expressing clones. The ability to isolate and expand pre-mesendodermal stage cells from human patients is a novel finding that holds potential value for applications in regenerative medicine.
first_indexed 2024-03-09T12:17:14Z
format Article
id doaj.art-df325dd47ee446c2a9210cd683a1909c
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T12:17:14Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-df325dd47ee446c2a9210cd683a1909c2023-11-30T22:45:31ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-01242178010.3390/ijms24021780Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell ClonesAndrea Monteon0Lorelei Hughes1Victor Camberos2Mary Kearns-Jonker3Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA 92350, USADepartment of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA 92350, USADepartment of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA 92350, USADepartment of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA 92350, USAThe utilization of cardiac progenitor cells (CPCs) has been shown to induce favorable regenerative effects. While there are various populations of endogenous CPCs in the heart, there is no consensus regarding which population is ideal for cell-based regenerative therapy. Early-stage progenitor cells can be differentiated into all cardiovascular lineages, including cardiomyocytes and endothelial cells. Identifying an Islet-1+ (Isl-1+) early-stage progenitor population with enhanced stemness, multipotency and differentiation potential would be beneficial for the development of novel regenerative therapies. Here, we investigated the transcriptome of human neonatal Isl-1+ CPCs. Isl-1+ human neonatal CPCs exhibit enhanced stemness properties and were found to express Spalt-like transcription factor 4 (SALL4). SALL4 plays a role in embryonic development as well as proliferation and expansion of hematopoietic progenitor cells. SALL4, SOX2, EpCAM and TBX5 are co-expressed in the majority of Isl-1+ clones isolated from neonatal patients. The pre-mesendodermal transcript TFAP2C was identified in select Isl-1, SALL4, SOX2, EpCAM and TBX5 expressing clones. The ability to isolate and expand pre-mesendodermal stage cells from human patients is a novel finding that holds potential value for applications in regenerative medicine.https://www.mdpi.com/1422-0067/24/2/1780Islet-1cardiovascular progenitor cellsSALL4
spellingShingle Andrea Monteon
Lorelei Hughes
Victor Camberos
Mary Kearns-Jonker
Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones
International Journal of Molecular Sciences
Islet-1
cardiovascular progenitor cells
SALL4
title Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones
title_full Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones
title_fullStr Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones
title_full_unstemmed Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones
title_short Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones
title_sort identification of sall4 expressing islet 1 cardiovascular progenitor cell clones
topic Islet-1
cardiovascular progenitor cells
SALL4
url https://www.mdpi.com/1422-0067/24/2/1780
work_keys_str_mv AT andreamonteon identificationofsall4expressingislet1cardiovascularprogenitorcellclones
AT loreleihughes identificationofsall4expressingislet1cardiovascularprogenitorcellclones
AT victorcamberos identificationofsall4expressingislet1cardiovascularprogenitorcellclones
AT marykearnsjonker identificationofsall4expressingislet1cardiovascularprogenitorcellclones